has been cited by the following article(s):
[1]
|
Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes
|
|
European journal of …,
2022 |
|
|
[2]
|
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
|
|
2019 |
|
|
[3]
|
Quantitative Fluorescence Measurements with Multicolor Flow Cytometry
|
|
Flow Cytometry Protocols,
2018 |
|
|
[4]
|
Consistent, multi‐instrument single tube quantification of CD 20 in antibody bound per cell based on CD 4 reference
|
|
Cytometry Part A,
2016 |
|
|
[5]
|
Quantitative Flow Cytometry Measurements in Antibodies Bound per Cell Based on a CD4 Reference
|
|
Current Protocols in Cytometry,
2016 |
|
|
[6]
|
Quantification of cells with specific phenotypes II: Determination of CD4 expression level on reconstituted lyophilized human PBMC labelled with anti‐CD4 …
|
|
Cytometry Part A,
2015 |
|
|
[7]
|
Quantification of cells with specific phenotypes II: Determination of CD4 expression level on reconstituted lyophilized human PBMC labelled with anti‐CD4 FITC antibody
|
|
Cytometry Part A,
2015 |
|
|
[8]
|
Recommendations for the development and validation of flow cytometry‐based receptor occupancy assays
|
|
Cytometry Part B: Clinical Cytometry,
2015 |
|
|
[9]
|
Consistent, multi‐instrument single tube quantification of CD20 in antibody bound per cell based on CD4 reference
|
|
Cytometry Part B: Clinical Cytometry,
2015 |
|
|
[10]
|
Quantification of cells with specific phenotypes II: Determination of CD4 expression level on reconstituted lyophilized human PBMC labelled with anti‐CD4 FITC …
|
|
Cytometry Part A,
2015 |
|
|